Obesity and diabetes as high‐risk factors for severe coronavirus disease 2019 (Covid‐19)
Open Access
- 26 June 2020
- journal article
- review article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 37 (2), e3377
- https://doi.org/10.1002/dmrr.3377
Abstract
The outbreak of the coronavirus disease 2019 (Covid‐19) has become an evolving worldwide health crisis. With the rising prevalence of obesity and diabetes has come an increasing awareness of their impacts on infectious diseases, including increased risk for various infections, post‐infection complications and mortality from critical infections. Although epidemiological and clinical characteristics of Covid‐19 have been constantly reported, no article has systematically illustrated the role of obesity and diabetes in Covid‐19, or how Covid‐19 affects obesity and diabetes, or special treatment in these at‐risk populations. Here, we present a synthesis of the recent advances in our understanding of the relationships between obesity, diabetes and Covid‐19 along with the underlying mechanisms, and provide special treatment guidance for these at‐risk populations.Keywords
This publication has 180 references indexed in Scilit:
- Natural Killer Cell Function, an Important Target for Infection and Tumor Protection, Is Impaired in Type 2 DiabetesPLOS ONE, 2013
- B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profileProceedings of the National Academy of Sciences of the United States of America, 2013
- Oseltamivir and Oseltamivir Carboxylate Pharmacokinetics in Obese Adults: Dose Modification for Weight Is Not NecessaryAntimicrobial Agents and Chemotherapy, 2011
- Metabolic and neurologic consequences of chronic lopinavir/ritonavir administration to C57BL/6 miceAntiviral Research, 2010
- Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009)Thorax, 2010
- Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortalityAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetesNature Reviews Molecular Cell Biology, 2008
- Adiponectin as an anti-inflammatory factorClinica Chimica Acta; International Journal of Clinical Chemistry, 2007
- Inflammation and metabolic disordersNature, 2006
- Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetesClinical and Experimental Immunology, 2006